atovaquone has been researched along with Eye Infections, Parasitic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armitage, KB; Blossom, DB; King, CH | 1 |
de Smet, MD; Lopez, JS; Masur, H; Mueller, BU; Nussenblatt, RB; Pizzo, PA | 1 |
2 other study(ies) available for atovaquone and Eye Infections, Parasitic
Article | Year |
---|---|
Occult Plasmodium vivax infection diagnosed by a polymerase chain reaction-based detection system: a case report.
Topics: Adult; Animals; Antimalarials; Atovaquone; Drug Therapy, Combination; Eye Infections, Parasitic; Female; Humans; Malaria, Vivax; Naphthoquinones; Plasmodium vivax; Polymerase Chain Reaction; Proguanil; Travel; Treatment Outcome; Zambia | 2005 |
Orally administered 566C80 for treatment of ocular toxoplasmosis in a patient with the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adolescent; Antiprotozoal Agents; Atovaquone; Eye Infections, Parasitic; Follow-Up Studies; Fundus Oculi; Humans; Male; Naphthoquinones; Toxoplasmosis, Ocular | 1992 |